IL-1 receptor antagonist attenuates proinflammatory responses to rhinovirus in airway epithelium
Journal of Allergy and Clinical Immunology · 2023
DOI: 10.1016/j.jaci.2023.01.015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2023. Verfasst von Stephen A Schworer und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy and Immunology, Department of Pediatrics, UNC School of Medicine, Chapel Hill, NC; Marsico Lung Institute, University of North Ca…. Hauptthemen laut MEDLINE: Asthma, Enterovirus Infections, Picornaviridae Infections. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, NIAID NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: Rhinoviruses (RVs) are the most common trigger for asthma exacerbations, and there are currently no targeted therapies for viral-induced asthma exacerbations. RV infection causes neutrophilic inflammation, which is often resistant to effects of glucocorticoids. IL-1 receptor antagonist (IL-1RA) treatment reduces neutrophilic inflammation in humans challenged with inhaled endotoxin and thus may have therapeutic potential for RV-induced asthma exacerbations. OBJECTIVE: We sought to test the hypothesis that IL-1RA treatment of airway epithelium reduces RV-mediated proinflammatory cytokine production, which is important for neutrophil recruitment. METHODS: Human bronchial epithelial cells from deceased donors without prior pulmonary disease were cultured at air-liquid interface and treated with IL-13 to approximate an asthmatic inflammatory milieu. Human bronchial epithelial cells were infected with human RV-16 with or without IL-1RA treatment. RESULTS: RV infection promoted the release of IL-1α and the neutrophil-attractant cytokines IL-6, IL-8, and CXCL10. Proinflammatory cytokine secretion was significantly reduced by IL-1RA treatment without significant change in IFN-β release or RV titer. In addition, IL-1RA reduced MUC5B expression after RV infection without impacting MUC5AC. CONCLUSIONS: These data suggest that IL-1RA treatment significantly reduced proinflammatory cytokines while preserving the antiviral response. These results provide evidence for further investigation of IL-1RA as a novel targeted therapy against neutrophil-attractant cytokine release in RV-induced airway inflammatory responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Allergy and Immunology, Department of Pediatrics, UNC School of Medicine, Chapel Hill, NC; Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC.
- Division of Allergy and Immunology, Department of Pediatrics, UNC School of Medicine, Chapel Hill, NC.
- Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC.
- Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC.
- Campbell University College of Pharmacy and Health Sciences, Buies Creek, NC.
- Division of Allergy and Immunology, Department of Pediatrics, UNC School of Medicine, Chapel Hill, NC. Electronic address: michelle_hernandez@med.unc.edu.
Förderung
- NIEHS NIH HHS
- NIAID NIH HHS
- NHLBI NIH HHS
- NCATS NIH HHS
- National Heart, Lung, and Blood Institute
- National Institute of Allergy and Infectious Diseases
- NCATS
- National Institutes of Health
Zitieren
APA
Schworer, S. A., Chason, K. D., Chen, G., Chen, J., Zhou, H., Burbank, A. J., Kesic, M. J., & Hernandez, M. L. (2023). IL-1 receptor antagonist attenuates proinflammatory responses to rhinovirus in airway epithelium. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2023.01.015
Vancouver
Schworer SA, Chason KD, Chen G, Chen J, Zhou H, Burbank AJ, et al. IL-1 receptor antagonist attenuates proinflammatory responses to rhinovirus in airway epithelium. Journal of Allergy and Clinical Immunology. 2023. doi:10.1016/j.jaci.2023.01.015
BibTeX
@article{Schworer2023,
author = {Schworer, Stephen A and Chason, Kelly D and Chen, Gang and Chen, Jie and Zhou, Haibo and Burbank, Allison J and Kesic, Matthew J and Hernandez, Michelle L},
title = {IL-1 receptor antagonist attenuates proinflammatory responses to rhinovirus in airway epithelium},
journal = {Journal of Allergy and Clinical Immunology},
year = {2023},
doi = {10.1016/j.jaci.2023.01.015}
}
EUVIMED